Knoke M, Schwesinger G. One hundred years ago: the history of cryptococcosis in Greifswald. Medical mycology in the nineteenth century. Mycoses. 1994;37:229–33.
DOI: https://doi.org/10.1111/j.1439-0507.1994.tb00418.x
Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525–30.
DOI: https://doi.org/10.1097/QAD.0b013e328322ffac
Litvintseva A, Marra R, Nielsen K, et al. Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa. Eukaryot Cell. 2003; 2(6):1162–8.
DOI: https://doi.org/10.1128/EC.2.6.1162-1168.2003
Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016 Mar;30(1):179-206. doi: 10.1016/j.idc.2015.10.006. PMID: 26897067; PMCID: PMC5808417.
DOI: https://doi.org/10.1016/j.idc.2015.10.006
Thakur K, Wilson M. Chronic Meningitis. CONTINUUM: Lifelong Learning in Neurology. 2018;24(5):1298-1326.
DOI: https://doi.org/10.1212/CON.0000000000000664
Zhu LP, Wu JQ, Xu B, et al. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007. Med Mycol 2010;48(4):570–579. doi:10.3109/13693780903437876. [PubMed: 20392150.
DOI: https://doi.org/10.3109/13693780903437876
Hagen F, Khayhan K, Theelen B, et al. Recognition of seven species in the Cryptococcus gatti/Cryptococcus neoformans species complex. Fungal Genet Biol 2015;78:16–48.
DOI: https://doi.org/10.1016/j.fgb.2015.02.009
Lin X, Hull C, Heitman J. Sexual reproduction between partners of the same mating type in Cryptococcus neoformans. Nature. 2005; 434:1017–21. [PubMed: 15846346]
DOI: https://doi.org/10.1038/nature03448
Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis. 1999; 179:449–54. [PubMed: 9878030]
DOI: https://doi.org/10.1086/314606
Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am. 2002; 16:837–74. [PubMed: 12512184].
DOI: https://doi.org/10.1016/S0891-5520(02)00036-3
Firacative, C., Lizarazo, J., Illnait-Zaragozí, M. and Castañeda, E., 2018. The status of cryptococcosis in Latin America. Memórias do Instituto Oswaldo Cruz, 113(7).
DOI: https://doi.org/10.1590/0074-02760170554
Galnares-Olalde, J., Loza-Jalil, S., Gómez-Peña, F., Muñoz-Abraham, O., Pavía-Aubry, V. and de Luna-Gallardo, D., 2014. Criptococosis meníngea en un paciente inmunocompetente: reporte de un caso y revisión de la literatura. Revista Médica Del Hospital General De México, 77(3), pp.137-141.
DOI: https://doi.org/10.1016/j.hgmx.2014.08.004
Escandón P, De Bedout C, Lizarazo J, Agudelo C, Tobón Á, Bello S et al. Criptococosis en Colombia: resultados de la encuesta nacional, 2006-2010. Biomédica. 2012;32(3).
DOI: https://doi.org/10.7705/biomedica.v32i3.707
Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000; 31:499–508. [PubMed: 10987712]
DOI: https://doi.org/10.1086/313992
Brizendine K, Baddley J, Pappas P. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2011;32(6):727–34.
DOI: https://doi.org/10.1055/s-0031-1295720
Escandón, P., Lizarazo, J., Agudelo, C. and Castañeda, E., 2018. Cryptococcosis in Colombia: Compilation and Analysis of Data from Laboratory-Based Surveillance. Journal of Fungi, 4(1), p.32.
DOI: https://doi.org/10.3390/jof4010032
Phillips P, Galanis E, MacDougall L, et al. Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia.Clin Infect Dis 2015;60(9):1368–76
DOI: https://doi.org/10.1093/cid/civ041
Panackal AA, Williamson PR. Fungal Infections of the Central Nervous System. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1662-78. doi: 10.1212/CON.0000000000000241. PMID: 26633781.
DOI: https://doi.org/10.1212/CON.0000000000000241
Antinori S. New Insights into HIV/AIDS-Associated Cryptococcosis. ISRN AIDS 2013;2013:471363.
DOI: https://doi.org/10.1155/2013/471363
Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994;32:1680–4.
DOI: https://doi.org/10.1128/jcm.32.7.1680-1684.1994
Wu TC, Koo SY. Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol 1983;18:1127–30.
DOI: https://doi.org/10.1128/jcm.18.5.1127-1130.1983
Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma and urine from patients with HIV associated cryptococcal meningitis. Clin Infect Dis 2011;53:1019–23.
DOI: https://doi.org/10.1093/cid/cir613
Tan ZR, Long XY, Li GL, Zhou JX, Long L. Spectrum of neuroimaging findings in cryptococcal meningitis in immunocompetent patients in China - A series of 18 cases. J Neurol Sci. 2016 Sep 15;368:132-7. doi: 10.1016/j.jns.2016.06.069. Epub 2016 Jul 1. PMID: 27538616.
DOI: https://doi.org/10.1016/j.jns.2016.06.069
Sarkis RA, Mays M, Isada C, Ahmed M. MRI findings in cryptococcal meningitis of the non-HIV population. Neurologist. 2015 Jan;19(2):40-5. doi: 10.1097/NRL.0000000000000000. PMID: 25607331.
DOI: https://doi.org/10.1097/NRL.0000000000000000
Bozette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment for cryptococcal meningitis in the Acquired Immunodeficiency Syndrome. N Engl J Med 1991;324:580–4.
DOI: https://doi.org/10.1056/NEJM199102283240902
Denning DW, Tucker RM, Hanson LH, et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301–8.
DOI: https://doi.org/10.1001/archinte.149.10.2301
Franco-Paredes C, Womack T, Bohlmeyer T, et al. Management of Cryptococcus gattii meningoencephalitis. Lancet Infect Dis 2015;15:348–55.
DOI: https://doi.org/10.1016/S1473-3099(14)70945-4